1M.L. Boshuisen,J.A. den Boer. [J] 2000,Psychopharmacology(1):74～79
2Kamini L. Ho Pian,H. G. M. Westenberg,Harold J. G. M. van Megen,Johan A. den Boer. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder[J] 1998,Psychopharmacology(3):365～370
7Bond M.Empirical Study of self-rated defense styles[J].Arch Gen Psychiatry,1983,40(3):333
8沈渔邮.精神病学[M].第4版.北京:人民卫生出版社,2005:327-329.
9Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence [J]. J ClinPsychiatry, 2004, 65(Suppl 14):11-17.
10Denys D,Zohar J,Westenberg HG.The role of dopamine in obsessive-compulsive disorder:preclinical and clinical evidence[J].J Clin Psychiatry,2004,65(Suppl)14:11-17.
